BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2022 1:17:37 PM | Browse: 332 | Download: 650
 |
Received |
|
2022-02-23 22:26 |
|
Peer-Review Started |
|
2022-02-23 22:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-05 13:07 |
|
Revised |
|
2022-04-19 21:20 |
|
Second Decision |
|
2022-06-15 02:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-16 18:04 |
|
Articles in Press |
|
2022-06-16 18:04 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-06-11 12:57 |
|
Typeset the Manuscript |
|
2022-07-01 04:01 |
|
Publish the Manuscript Online |
|
2022-07-27 13:17 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vladimir Ivashkin, Albina Ismailova, Ksenia Dmitrieva, Roman Maslennikov, Maria Zharkova, Salehk Aliev, Vyacheslav Bakhitov and Vadim Marcinkevich |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Roman Maslennikov, MD, PhD, Assistant Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinskaya 1-1, Moscow 119435, Russia. mmmm00@yandex.ru |
| Key Words |
Coronavirus; Vaccination; Revaccination; Booster; SARS-CoV-2; Sputnik V |
| Core Tip |
The aim of the study was to evaluate the clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis. No severe cases of COVID-19 were revealed in the vaccinated group. The vaccine efficacy was 69.5% (95% confidence interval [CI]: 18.5%-94.4%) against symptomatic cases of COVID-19, 100% (95%CI: 25.1%-100.0%) against severe cases, and 100% (95%CI: 1.6%-100.0%) against death associated with COVID-19. There was no significant difference in liver-related mortality, or the incidence of liver decompensation, bleeding esophageal varices, and vascular events between the two groups of patients. Vaccination against COVID-19 in patients with cirrhosis is effective and safe. |
| Publish Date |
2022-07-27 13:17 |
| Citation |
Ivashkin V, Ismailova A, Dmitrieva K, Maslennikov R, Zharkova M, Aliev S, Bakhitov V, Marcinkevich V. Efficacy and safety of COVID-19 vaccination in patients with cirrhosis. World J Hepatol 2022; 14(7): 1470-1479 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i7/1470.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i7.1470 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
